Preferred Label : ambenonium chloride;
MeSH definition : A quaternary ammonium compound that is an inhibitor of cholinesterase activity with
actions similar to those of NEOSTIGMINE, but of longer duration. Ambenonium is given
by mouth in the treatment of myasthenia gravis. (From Martindale, The Extra Pharmacopoeia,
30th ed, p1112);
MeSH synonym : chloride, ambenonium;
CISMeF synonym : sanofi winthrop brand of ambenonium chloride;
MeSH hyponym : mytelase;
MeSH CAS label : benzenemethanaminium, N,N'-((1,2-dioxo-1,2-ethanediyl)bis(imino-2,1-ethanediyl))bis(2-chloro-N,N-diethyl)-,
dichloride;
MeSH Related Number : 115-79-7 (Ambenonium chloride);
Registry Number MeSH : 115-79-7;
Codes EINECS : 204-107-5;
Is substance : O;
UNII : 51FOB87G3I;
InChIKey : DXUUXWKFVDVHIK-UHFFFAOYSA-N;
Origin ID : D000549;
UMLS CUI : C0002413;
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT
A quaternary ammonium compound that is an inhibitor of cholinesterase activity with
actions similar to those of NEOSTIGMINE, but of longer duration. Ambenonium is given
by mouth in the treatment of myasthenia gravis. (From Martindale, The Extra Pharmacopoeia,
30th ed, p1112)
http://www.has-sante.fr/portail/jcms/c_2655956/fr/mytelase
http://www.has-sante.fr/portail/jcms/c_1098675/mytelase
http://www.has-sante.fr/portail/jcms/c_468409/fr/mytelase
2016
false
France
French
treatment outcome
insurance, health, reimbursement
myasthenia gravis
evaluation of the transparency committee
ambenonium chloride
administration, oral
ambenonium
parasympathomimetics
cholinesterase inhibitors
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60374821
2010
France
French
ambenonium chloride
ambenonium chloride
tablets
administration, oral
ambenonium
myasthenia gravis
drug interactions
pregnancy
breast feeding
cholinesterase inhibitors
cholinesterase inhibitors
parasympathomimetics
parasympathomimetics
summary of product characteristics
package leaflet
---